CD4 and COVID-19: The other confirmatory assessments regarding the associative pathophysiology of sarcoidosis and COVID‐19 rely on the pathological examination of lung biopsy tissues from COVID‐19 patients, showing the presence of inflammatory clusters, including multinucleated giant cells (MGCs) and CD4+ T lymphocytes, an observation reminiscent of MGCs in sarcoidosis.8